{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:01:56Z","timestamp":1777431716538,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jss.2015.05.048","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T14:20:35Z","timestamp":1432909235000},"page":"155-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Quality of life after treatment of neuroendocrine liver metastasis"],"prefix":"10.1016","volume":"198","author":[{"given":"Gaya","family":"Spolverato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Bagante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Buettner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhree","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadia","family":"Maqsood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2015.05.048_bib1","doi-asserted-by":"crossref","first-page":"R445","DOI":"10.1530\/ERC-14-0106","article-title":"Hallmarks of gastrointestinal neuroendocrine tumours: implications for treatment","volume":"21","author":"Walenkamp","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jss.2015.05.048_bib2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejrad.2008.08.008","article-title":"Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation","volume":"72","author":"Vogl","year":"2009","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jss.2015.05.048_bib3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.suc.2010.04.016","article-title":"Neuroendocrine liver metastases","volume":"90","author":"Reddy","year":"2010","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.jss.2015.05.048_bib4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1677\/ERC-08-0247","article-title":"Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience","volume":"16","author":"Scigliano","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jss.2015.05.048_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1072-7515(03)00230-8","article-title":"Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival","volume":"197","author":"Sarmiento","year":"2003","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jss.2015.05.048_bib6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1072-7515(00)00222-2","article-title":"Hepatic neuroendocrine metastases: does intervention alter outcomes?","volume":"190","author":"Chamberlain","year":"2000","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jss.2015.05.048_bib7","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1245\/s10434-010-1154-5","article-title":"Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis","volume":"17","author":"Mayo","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2015.05.048_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000335597","article-title":"ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary","volume":"95","author":"Pavel","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jss.2015.05.048_bib9","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1245\/s10434-011-1832-y","article-title":"Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis","volume":"18","author":"Mayo","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2015.05.048_bib10","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2214\/AJR.06.0933","article-title":"Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors","volume":"188","author":"Ho","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jss.2015.05.048_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2214\/AJR.07.2550","article-title":"Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization","volume":"190","author":"Liapi","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jss.2015.05.048_bib12","doi-asserted-by":"crossref","DOI":"10.1159\/000381715","article-title":"Impact of previous somatostatin analogue use on the activity of everolimus in patients with advanced neuroendocrine tumors: analysis from the phase III RADIANT-2 Trial","author":"Anthony","year":"2015","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jss.2015.05.048_bib13","first-page":"457","article-title":"The role of chemotherapy and\/or octreotide in patients with metastatic gastroenteropancreatic and hepatobiliary neuroendocrine carcinoma","volume":"5","author":"Lee","year":"2014","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.jss.2015.05.048_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1530\/ERC-14-0086","article-title":"Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures","volume":"21","author":"Mohamed","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jss.2015.05.048_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jamcollsurg.2012.08.027","article-title":"Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies","volume":"216","author":"Mayo","year":"2013","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jss.2015.05.048_bib16","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/MPA.0b013e31819b6441","article-title":"Development of the Norfolk quality of life tool for assessing patients with neuroendocrine tumors","volume":"38","author":"Vinik","year":"2009","journal-title":"Pancreas"},{"key":"10.1016\/j.jss.2015.05.048_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ejca.2005.10.025","article-title":"Development of a disease-specific quality of life questionnaire module for patients with gastrointestinal neuroendocrine tumours","volume":"42","author":"Davies","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jss.2015.05.048_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/bjc.2012.560","article-title":"Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours","volume":"108","author":"Yadegarfar","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jss.2015.05.048_bib19","first-page":"1011","article-title":"Islet cell carcinomas of the pancreas: a twenty-year experience","volume":"104","author":"Thompson","year":"1988","journal-title":"Surgery"},{"key":"10.1016\/j.jss.2015.05.048_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1072-7515(98)00099-4","article-title":"Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?","volume":"187","author":"Chen","year":"1998","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jss.2015.05.048_bib21","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1245\/ASO.2003.04.533","article-title":"Long-term survival after resection for primary hepatic carcinoid tumor","volume":"10","author":"Knox","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2015.05.048_bib22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1245\/ASO.2006.03.071","article-title":"Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors","volume":"13","author":"Osborne","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.jss.2015.05.048_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000080747","article-title":"Chemotherapy for gastro-enteropancreatic endocrine tumours","volume":"80","author":"O'Toole","year":"2004","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jss.2015.05.048_bib24","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1200\/JCO.1984.2.11.1255","article-title":"Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor","volume":"2","author":"Engstrom","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2015.05.048_bib25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/PPO.0b013e3181d7e905","article-title":"Chemoembolization for primary and metastatic liver cancer","volume":"16","author":"Liapi","year":"2010","journal-title":"Cancer J"},{"key":"10.1016\/j.jss.2015.05.048_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/hpb.12225","article-title":"When should a liver resection be performed in patients with liver metastases from neuroendocrine tumours? A systematic review with practice recommendations","volume":"17","author":"Lesurtel","year":"2015","journal-title":"HPB"},{"issue":"Suppl 3","key":"10.1016\/j.jss.2015.05.048_bib27","doi-asserted-by":"crossref","first-page":"S220","DOI":"10.1245\/s10434-010-1343-2","article-title":"Surgical management and emerging therapies to prolong survival in metastatic neuroendocrine cancer","volume":"18","author":"Mayo","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2015.05.048_bib28","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/cncr.21389","article-title":"Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival","volume":"104","author":"Gupta","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2015.05.048_bib29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00330-002-1558-0","article-title":"Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors","volume":"13","author":"Roche","year":"2003","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jss.2015.05.048_bib30","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2293::AID-CNCR8>3.0.CO;2-E","article-title":"Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors","volume":"83","author":"Eriksson","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2015.05.048_bib31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00130404-200307000-00008","article-title":"Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience","volume":"9","author":"Gupta","year":"2003","journal-title":"Cancer J"},{"key":"10.1016\/j.jss.2015.05.048_bib32","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1200\/JCO.2008.16.7858","article-title":"Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2015.05.048_bib33","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(11)61742-X","article-title":"Everolimus plus octreotide long-acting repeatable for the treatment\u00a0of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study","volume":"378","author":"Pavel","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jss.2015.05.048_bib34","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/EJA.0b013e328328f552","article-title":"Evaluation of physical and mental recovery status after elective liver resection","volume":"26","author":"Arnberger","year":"2009","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.jss.2015.05.048_bib35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/archsurg.136.6.693","article-title":"A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma","volume":"136","author":"Poon","year":"2001","journal-title":"Arch Surg"},{"key":"10.1016\/j.jss.2015.05.048_bib36","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.surg.2007.04.026","article-title":"Health-related quality of life: return to baseline after major and minor liver resection","volume":"142","author":"Martin","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.jss.2015.05.048_bib37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/bjs.7365","article-title":"Long-term global quality of life in patients treated for colorectal liver metastases","volume":"98","author":"Wiering","year":"2011","journal-title":"Br J Surg"},{"key":"10.1016\/j.jss.2015.05.048_bib38","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00268-009-0032-4","article-title":"Long-term quality of life after hepatic resection: health is not simply the absence of disease","volume":"33","author":"Banz","year":"2009","journal-title":"World J Surg"},{"key":"10.1016\/j.jss.2015.05.048_bib39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.surg.2012.05.004","article-title":"Improvements in quality of life after surgery for benign hepatic tumors: results from a dual center analysis","volume":"152","author":"Kneuertz","year":"2012","journal-title":"Surgery"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480415006599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480415006599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T21:11:37Z","timestamp":1599081097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480415006599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0022480415006599"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2015.05.048","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of life after treatment of neuroendocrine liver metastasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2015.05.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}